Timothy Kuzel, MD
Medical Oncology · Orland Park, ILNPI 1851325088
Payments from drug & device makers
Across 484 payments — averaging $2793.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$386K
- Exelixis Inc.$339K
- Seagen Inc.$186K
- Eisai Inc.$97K
- Pfizer$96K
- Merck$92K
- plus $157K from 19 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 42 | $386,048 |
| Exelixis Inc. | 124 | $338,719 |
| Seagen Inc. | 51 | $185,681 |
| Eisai Inc. | 64 | $97,409 |
| Pfizer | 13 | $95,707 |
| Merck | 68 | $91,550 |
| Janssen Research & Development, LLC | 11 | $40,604 |
| Incyte Corporation | 40 | $32,812 |
| Sun Pharmaceutical Industries Inc. | 26 | $30,426 |
| Sanofi | 9 | $10,120 |
| Clinigen, Inc. | 1 | $9,684 |
| Immunocore Limited | 2 | $6,400 |
| Amgen | 6 | $5,011 |
| Novartis | 4 | $4,880 |
| Astellas Pharma Global Development | 2 | $4,776 |
| Kyowa Kirin, Inc. | 4 | $3,462 |
| Janssen Scientific Affairs, LLC | 8 | $2,619 |
| AbbVie | 1 | $2,444 |
| Genentech, Inc. | 1 | $2,145 |
| Johnson & Johnson | 2 | $1,190 |
| Telix Pharmaceuticals | 1 | $149 |
| Tempus AI, Inc | 1 | $122 |
| Comsort, Inc | 1 | $100 |
| Acrotech Biopharma Inc. | 1 | $14 |
| Array Biopharma Inc | 1 | $6 |
How this compares
$1,352,075 in reported general payments places this provider in the 85th percentile of 144 medical oncology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical oncology in Orland Park
- Andrzej JakubowiakChicago$42M
- Alexander PearsonChicago$9.3M
- Jyoti PatelChicago$7.5M
- Devalingam MahalingamChicago$7.1M
- Ardaman ShergillChicago$4.9M
- Sunandana ChandraChicago$4.6M
- William GradisharChicago$3.3M
- Manali BhaveChicago$3.3M
- Eugene AhnChicago$2.8M
- James WadeDecatur$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.